Micro Lecture: RNA based vaccines

Date 2021-01-15

Department Head Christoph Griesbeck informs about RNA based SARS-CoV-2 vaccines

“Students asked me repeatedly about current developments regarding RNA based vaccines against COVID-19 and about an objective and scientifically based assessment,” says Prof. Dr. Christoph Griesbeck, Head of Department and studies for Biotechnology and Food Engineering at MCI. To answer all the questions of the students, he recorded a Micro Lecture. In this short lecture, Christoph Griesbeck answers the following questions:

  • How do RNA vaccines work?
  • Why do they not change the human genome?
  • What are lipid nanoparticles?
  • Why could these vaccines be developed and approved so quickly?
<p><em>Micro Lecture with Head of Department and Studies Christoph Griesbeck, Foto: MCI</em></p>

Micro Lecture with Head of Department and Studies Christoph Griesbeck, Foto: MCI

The Micro Lecture is connected to different courses of the bachelors' program Biotechnology and Food Engineering and the Master’s program Biotechnology, e.g. Molecular Cell Biology and Genetics, Biochemistry and Immunology und Preclinical & Clinical Development.

<p><em>Micro Lecture about RNA based vaccination, Foto: MCI </em></p>

Micro Lecture about RNA based vaccination, Foto: MCI

<p><em>Micro Lecture with Head of Department and Studies Christoph Griesbeck, Foto: MCI </em></p>

Micro Lecture with Head of Department and Studies Christoph Griesbeck, Foto: MCI

<p><em>Micro Lecture about RNA based vaccination, Foto: MCI </em></p>
<p><em>Micro Lecture with Head of Department and Studies Christoph Griesbeck, Foto: MCI </em></p>
Study program informations
 MCI and University of Genoa Launch Double Degree in Medical-Pharmaceutical Biotechnology
MCI and University of Genoa Launch Double Degree in Medical-Pharmaceutical Biotechnology
MCI and the University of Genoa sign contract for new double degree program
DOUBLE DEGREE
DOUBLE DEGREE "INTERNATIONAL BIOPHARMA" STARTS ITS 2ND YEAR
Students report about their time abroad so far
Biotechnet SUMMER SCHOOL WAS A GREAT SUCCESS
Biotechnet SUMMER SCHOOL WAS A GREAT SUCCESS
150 participants at the four-day event